Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
To determine the relative efficacy of multidose medroxyprogesterone acetate (MPA, Provera)
and a multidose, monophasic combination oral contraceptive in the treatment of
hemodynamically stable women with non-gestational, acute uterine bleeding.